We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App




New Robotic Solution Enhances Workflow Within Compact Footprint

By LabMedica International staff writers
Posted on 19 Jan 2015
An advance in compact robotic laboratory automation solutions, a new instrument consolidates sample management for chemistry and immunoassay testing and achieves some of the workflow benefits of automation without the space or budget associated with a track-based solution.

Siemens Healthcare Diagnostics of Siemens Healthcare (Frimley, UK), a leader in medical imaging, laboratory diagnostics, medical information technology, and hearing aids, has unveiled the VersaCell X3, featuring increased analytical capacity through a single sample interface with three-instrument connectivity. More...
The one-touch sample management empowers laboratories to advance workflow capabilities and streamline processes to meet their needs. With advanced sorting capabilities, the VersaCell X3 can improve the pre- and post-analytical process and reduce operator hands-on-time.

A priority drawer provides 8 new STAT positions and frees up 50 sample positions for routine processing, increasing sample routing flexibility. Its signature robotic arm delivers individual samples to connected analyzers to help drive towards a predictable turnaround time. The inclusion of a new docking plate reduces service intervention time for all connected systems, supporting uptime so laboratories can deliver timely results to clinicians. Further data consolidation is achievable through a connection to Siemens’ “CentraLink Data Management System.”

“The VersaCell X3 is a new design which provides enhanced capabilities and a harmonized look and feel across our next generation of solutions,” said Catherine Spurgeon, marketing manager for Automation, Siemens Healthcare Diagnostics, “In line with our commitment to continuously advance workflow capabilities, some of our existing VersaCell Systems can be upgraded with the VersaCell X3 Expansion Pack.” She added, “This will enable labs to connect up to three Siemens systems and improve the operator experience with new software and advanced sorting capabilities on their existing VersaCell solution. The VersaCell X3 complements the recent launch of the Siemens Aptio Automation track-based solution, designed for medium- to very high-volume laboratories. We are delighted that the first UK installation has now taken place.”

Related Links:

Siemens Healthcare



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Thyroid Test
Anti-Thyroid EIA Test
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: The Avantect Pancreatic Cancer Test combines epigenomic, genomic, and glycan biomarkers with machine learning to detect pancreatic cancer-associated signals in blood (Photo courtesy of ClearNote Health)

Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

Pancreatic ductal adenocarcinoma remains difficult to detect early and monitor during treatment, particularly in patients with homologous recombination defects. Clinicians also have limited noninvasive... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.